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TO THE EDITOR: The recent article by 
Demir et al. (2012) in your esteemed jour-
nal provided for highly stimulating and 
interesting reading. Interestingly, over the 
past few years artemin has been identified 
as a significant player in the enhancement 
of oncogenicity of various other tumors 
besides pancreatic cancers.
For instance, artemin enhances tran-
scription of bcl2 – leading to it’s up 
regulation and thereby augments tumor 
growth in human non-small cell lung 
carcinomas (Tang et al., 2010). Similarly, 
in estrogen receptor negative breast car-
cinomas, artemin shows synergization 
with TWIST1 and thereby accentuates the 
metastatic potential of the primary breast 
tumor (Banerjee et al., 2011). As a result, 
a poor clinical outcome is associated 
with this combination of artemin and 
TWIST1. Attenuated artemin expression 
is seen as a result of tamoxifen adminis-
tration (Kang et al., 2010). Interestingly, 
the sensitivity to tamoxifen of tamoxifen 
resistant mammary tissue is accentuated 
following antibody mediated inhibition 
of artemin.
Increased expression of artemin is also 
seen in esophageal carcinomas. Interestingly 
transfection with a mir-223 vector decreases 
expression of artemin and thereby sup-
presses tumor growth in esophageal carci-
nomas (Li et al., 2011). Similarly, artemin 
augments the expression of AKT1 and 
thereby accentuates the invasive potential 
of endometrial carcinomas (Pandey et al., 
2010). The invasive potential of endome-
trial cancer tissue is significantly abrogated 
following antibody mediated inhibition of 
artemin.
The above examples clearly illustrate 
the significant enhancement of oncogenic-
ity secondary to artemin in tumors ranging 
from lung carcinomas to endometrial car-
cinomas. There is a clear and urgent need 
to identify inhibitors of artemin function 
in order to improve the prognosis in these 
tumors.
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